Women’s preferences for vaginal antimicrobial contraceptives IV: Attributes of a formulation that would protect from STD/AIDS

Vaginal formulations may have “dual” protective activity, against sexually transmitted diseases/AIDS and unplanned pregnancy. The attributes that women find acceptable or unacceptable for such dual protective methods were investigated. More than 50% of the women would not accept messiness, but it wa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Contraception (Stoneham) 1998-10, Vol.58 (4), p.251-255
Hauptverfasser: Hardy, Ellen, de Pádua, Karla S, Osis, Maria José D, Jiménez, Ana Luisa, Zaneveld, Lourens J.D
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 255
container_issue 4
container_start_page 251
container_title Contraception (Stoneham)
container_volume 58
creator Hardy, Ellen
de Pádua, Karla S
Osis, Maria José D
Jiménez, Ana Luisa
Zaneveld, Lourens J.D
description Vaginal formulations may have “dual” protective activity, against sexually transmitted diseases/AIDS and unplanned pregnancy. The attributes that women find acceptable or unacceptable for such dual protective methods were investigated. More than 50% of the women would not accept messiness, but it was more accepted for dual protective methods than for contraceptives. Very few women would use a dual protective method if it caused vaginal irritation, itching, swelling, or burning, problems associated with presently marketed methods. More than half of the women would use it if it appeared on the penis of their partner or required refrigeration. Use of an applicator to insert the formulation was generally preferred over a manual method. Most women preferred the formulation to be colorless or white, about 16% liked light colors, and about 10% liked darker colors. Almost half of the women were willing to pay up to $5.00 per application of a dual protective formulation, about 15% $3.00, and 30% $1.00. Dual protective methods seem highly acceptable and women would pay much more for them than for condoms. However, these methods should be free of problems usually associated with presently marketed formulations.
doi_str_mv 10.1016/S0010-7824(98)00106-1
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_69101044</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0010782498001061</els_id><sourcerecordid>69101044</sourcerecordid><originalsourceid>FETCH-LOGICAL-e291t-a6d44c3d12888af350c3c50c34f41d5e6f78238ef72a15ab4a6697630754f2533</originalsourceid><addsrcrecordid>eNo9kc9u1DAQxi0EKkvhESr5gBAcQsex4zhc0Krlz0qVOGyBozXr2GCUxFvbWcQJXoPX40lw2lUvtj7NzzOe7yPkjMFrBkyebwEYVK2qxctOvVqErNgDsmKq7SpomHpIVvfIY_IkpR8A0HZNe0JOOiUlgFqR31_DaKd_f_4muo_W2WgnYxN1IdIDfvMTDhSn7EdvYtj5okyYckRj99kfCrj58oauc45-N-cig6O4PB7nAbMPE83fMdOfYR760j9kazJ1MYx0e315vt5cbp-SRw6HZJ8d71Py-f2764uP1dWnD5uL9VVl647lCmUvhOE9q5VS6HgDhpvlEE6wvrHSlS25sq6tkTW4Eyhl10oObSNc3XB-Sl7c9S2_uJltynr0ydhhwMmGOWnZFVNBiAKeHcF5N9pe76MfMf7SR8dK_fmxjsng4CJOxqd7jElgHKBgb-8wW5Y6eBt1Mn7xtvexmKD74DUDvSSpb5PUS0xlir5NUjP-H5pYkLw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69101044</pqid></control><display><type>article</type><title>Women’s preferences for vaginal antimicrobial contraceptives IV: Attributes of a formulation that would protect from STD/AIDS</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Hardy, Ellen ; de Pádua, Karla S ; Osis, Maria José D ; Jiménez, Ana Luisa ; Zaneveld, Lourens J.D</creator><creatorcontrib>Hardy, Ellen ; de Pádua, Karla S ; Osis, Maria José D ; Jiménez, Ana Luisa ; Zaneveld, Lourens J.D</creatorcontrib><description>Vaginal formulations may have “dual” protective activity, against sexually transmitted diseases/AIDS and unplanned pregnancy. The attributes that women find acceptable or unacceptable for such dual protective methods were investigated. More than 50% of the women would not accept messiness, but it was more accepted for dual protective methods than for contraceptives. Very few women would use a dual protective method if it caused vaginal irritation, itching, swelling, or burning, problems associated with presently marketed methods. More than half of the women would use it if it appeared on the penis of their partner or required refrigeration. Use of an applicator to insert the formulation was generally preferred over a manual method. Most women preferred the formulation to be colorless or white, about 16% liked light colors, and about 10% liked darker colors. Almost half of the women were willing to pay up to $5.00 per application of a dual protective formulation, about 15% $3.00, and 30% $1.00. Dual protective methods seem highly acceptable and women would pay much more for them than for condoms. However, these methods should be free of problems usually associated with presently marketed formulations.</description><identifier>ISSN: 0010-7824</identifier><identifier>EISSN: 1879-0518</identifier><identifier>DOI: 10.1016/S0010-7824(98)00106-1</identifier><identifier>PMID: 9866008</identifier><identifier>CODEN: CCPTAY</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Acquired Immunodeficiency Syndrome - prevention &amp; control ; Adolescent ; Adult ; AIDS ; AIDS/HIV ; Anti-Infective Agents - administration &amp; dosage ; Biological and medical sciences ; Birth control ; Brazil ; Color ; Consumer Behavior ; contraception ; Contraceptive Agents, Female - administration &amp; dosage ; contraceptive usage ; Female ; Gynecology. Andrology. Obstetrics ; Humans ; Medical sciences ; Middle Aged ; Odorants ; Other methods of contraception. Sterilization ; Pregnancy ; sexually transmitted diseases ; Sexually Transmitted Diseases - prevention &amp; control ; Socioeconomic Factors ; Vaginal Creams, Foams, and Jellies ; vaginal formulation</subject><ispartof>Contraception (Stoneham), 1998-10, Vol.58 (4), p.251-255</ispartof><rights>1998 Elsevier Science Inc.</rights><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0010782498001061$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1601300$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9866008$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hardy, Ellen</creatorcontrib><creatorcontrib>de Pádua, Karla S</creatorcontrib><creatorcontrib>Osis, Maria José D</creatorcontrib><creatorcontrib>Jiménez, Ana Luisa</creatorcontrib><creatorcontrib>Zaneveld, Lourens J.D</creatorcontrib><title>Women’s preferences for vaginal antimicrobial contraceptives IV: Attributes of a formulation that would protect from STD/AIDS</title><title>Contraception (Stoneham)</title><addtitle>Contraception</addtitle><description>Vaginal formulations may have “dual” protective activity, against sexually transmitted diseases/AIDS and unplanned pregnancy. The attributes that women find acceptable or unacceptable for such dual protective methods were investigated. More than 50% of the women would not accept messiness, but it was more accepted for dual protective methods than for contraceptives. Very few women would use a dual protective method if it caused vaginal irritation, itching, swelling, or burning, problems associated with presently marketed methods. More than half of the women would use it if it appeared on the penis of their partner or required refrigeration. Use of an applicator to insert the formulation was generally preferred over a manual method. Most women preferred the formulation to be colorless or white, about 16% liked light colors, and about 10% liked darker colors. Almost half of the women were willing to pay up to $5.00 per application of a dual protective formulation, about 15% $3.00, and 30% $1.00. Dual protective methods seem highly acceptable and women would pay much more for them than for condoms. However, these methods should be free of problems usually associated with presently marketed formulations.</description><subject>Acquired Immunodeficiency Syndrome - prevention &amp; control</subject><subject>Adolescent</subject><subject>Adult</subject><subject>AIDS</subject><subject>AIDS/HIV</subject><subject>Anti-Infective Agents - administration &amp; dosage</subject><subject>Biological and medical sciences</subject><subject>Birth control</subject><subject>Brazil</subject><subject>Color</subject><subject>Consumer Behavior</subject><subject>contraception</subject><subject>Contraceptive Agents, Female - administration &amp; dosage</subject><subject>contraceptive usage</subject><subject>Female</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Odorants</subject><subject>Other methods of contraception. Sterilization</subject><subject>Pregnancy</subject><subject>sexually transmitted diseases</subject><subject>Sexually Transmitted Diseases - prevention &amp; control</subject><subject>Socioeconomic Factors</subject><subject>Vaginal Creams, Foams, and Jellies</subject><subject>vaginal formulation</subject><issn>0010-7824</issn><issn>1879-0518</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kc9u1DAQxi0EKkvhESr5gBAcQsex4zhc0Krlz0qVOGyBozXr2GCUxFvbWcQJXoPX40lw2lUvtj7NzzOe7yPkjMFrBkyebwEYVK2qxctOvVqErNgDsmKq7SpomHpIVvfIY_IkpR8A0HZNe0JOOiUlgFqR31_DaKd_f_4muo_W2WgnYxN1IdIDfvMTDhSn7EdvYtj5okyYckRj99kfCrj58oauc45-N-cig6O4PB7nAbMPE83fMdOfYR760j9kazJ1MYx0e315vt5cbp-SRw6HZJ8d71Py-f2764uP1dWnD5uL9VVl647lCmUvhOE9q5VS6HgDhpvlEE6wvrHSlS25sq6tkTW4Eyhl10oObSNc3XB-Sl7c9S2_uJltynr0ydhhwMmGOWnZFVNBiAKeHcF5N9pe76MfMf7SR8dK_fmxjsng4CJOxqd7jElgHKBgb-8wW5Y6eBt1Mn7xtvexmKD74DUDvSSpb5PUS0xlir5NUjP-H5pYkLw</recordid><startdate>19981001</startdate><enddate>19981001</enddate><creator>Hardy, Ellen</creator><creator>de Pádua, Karla S</creator><creator>Osis, Maria José D</creator><creator>Jiménez, Ana Luisa</creator><creator>Zaneveld, Lourens J.D</creator><general>Elsevier Inc</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>19981001</creationdate><title>Women’s preferences for vaginal antimicrobial contraceptives IV: Attributes of a formulation that would protect from STD/AIDS</title><author>Hardy, Ellen ; de Pádua, Karla S ; Osis, Maria José D ; Jiménez, Ana Luisa ; Zaneveld, Lourens J.D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-e291t-a6d44c3d12888af350c3c50c34f41d5e6f78238ef72a15ab4a6697630754f2533</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Acquired Immunodeficiency Syndrome - prevention &amp; control</topic><topic>Adolescent</topic><topic>Adult</topic><topic>AIDS</topic><topic>AIDS/HIV</topic><topic>Anti-Infective Agents - administration &amp; dosage</topic><topic>Biological and medical sciences</topic><topic>Birth control</topic><topic>Brazil</topic><topic>Color</topic><topic>Consumer Behavior</topic><topic>contraception</topic><topic>Contraceptive Agents, Female - administration &amp; dosage</topic><topic>contraceptive usage</topic><topic>Female</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Odorants</topic><topic>Other methods of contraception. Sterilization</topic><topic>Pregnancy</topic><topic>sexually transmitted diseases</topic><topic>Sexually Transmitted Diseases - prevention &amp; control</topic><topic>Socioeconomic Factors</topic><topic>Vaginal Creams, Foams, and Jellies</topic><topic>vaginal formulation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hardy, Ellen</creatorcontrib><creatorcontrib>de Pádua, Karla S</creatorcontrib><creatorcontrib>Osis, Maria José D</creatorcontrib><creatorcontrib>Jiménez, Ana Luisa</creatorcontrib><creatorcontrib>Zaneveld, Lourens J.D</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Contraception (Stoneham)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hardy, Ellen</au><au>de Pádua, Karla S</au><au>Osis, Maria José D</au><au>Jiménez, Ana Luisa</au><au>Zaneveld, Lourens J.D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Women’s preferences for vaginal antimicrobial contraceptives IV: Attributes of a formulation that would protect from STD/AIDS</atitle><jtitle>Contraception (Stoneham)</jtitle><addtitle>Contraception</addtitle><date>1998-10-01</date><risdate>1998</risdate><volume>58</volume><issue>4</issue><spage>251</spage><epage>255</epage><pages>251-255</pages><issn>0010-7824</issn><eissn>1879-0518</eissn><coden>CCPTAY</coden><abstract>Vaginal formulations may have “dual” protective activity, against sexually transmitted diseases/AIDS and unplanned pregnancy. The attributes that women find acceptable or unacceptable for such dual protective methods were investigated. More than 50% of the women would not accept messiness, but it was more accepted for dual protective methods than for contraceptives. Very few women would use a dual protective method if it caused vaginal irritation, itching, swelling, or burning, problems associated with presently marketed methods. More than half of the women would use it if it appeared on the penis of their partner or required refrigeration. Use of an applicator to insert the formulation was generally preferred over a manual method. Most women preferred the formulation to be colorless or white, about 16% liked light colors, and about 10% liked darker colors. Almost half of the women were willing to pay up to $5.00 per application of a dual protective formulation, about 15% $3.00, and 30% $1.00. Dual protective methods seem highly acceptable and women would pay much more for them than for condoms. However, these methods should be free of problems usually associated with presently marketed formulations.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>9866008</pmid><doi>10.1016/S0010-7824(98)00106-1</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0010-7824
ispartof Contraception (Stoneham), 1998-10, Vol.58 (4), p.251-255
issn 0010-7824
1879-0518
language eng
recordid cdi_proquest_miscellaneous_69101044
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Acquired Immunodeficiency Syndrome - prevention & control
Adolescent
Adult
AIDS
AIDS/HIV
Anti-Infective Agents - administration & dosage
Biological and medical sciences
Birth control
Brazil
Color
Consumer Behavior
contraception
Contraceptive Agents, Female - administration & dosage
contraceptive usage
Female
Gynecology. Andrology. Obstetrics
Humans
Medical sciences
Middle Aged
Odorants
Other methods of contraception. Sterilization
Pregnancy
sexually transmitted diseases
Sexually Transmitted Diseases - prevention & control
Socioeconomic Factors
Vaginal Creams, Foams, and Jellies
vaginal formulation
title Women’s preferences for vaginal antimicrobial contraceptives IV: Attributes of a formulation that would protect from STD/AIDS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T20%3A52%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Women%E2%80%99s%20preferences%20for%20vaginal%20antimicrobial%20contraceptives%20IV:%20Attributes%20of%20a%20formulation%20that%20would%20protect%20from%20STD/AIDS&rft.jtitle=Contraception%20(Stoneham)&rft.au=Hardy,%20Ellen&rft.date=1998-10-01&rft.volume=58&rft.issue=4&rft.spage=251&rft.epage=255&rft.pages=251-255&rft.issn=0010-7824&rft.eissn=1879-0518&rft.coden=CCPTAY&rft_id=info:doi/10.1016/S0010-7824(98)00106-1&rft_dat=%3Cproquest_pubme%3E69101044%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69101044&rft_id=info:pmid/9866008&rft_els_id=S0010782498001061&rfr_iscdi=true